Emanuela Zuccaro

Padova, 35131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Androgen receptor and its coregulators in sex-biased diseases.

Androgen receptor and its coregulators in sex-biased diseases.

Journal: Trends in molecular medicine

Published: February 18, 2025

Kv3 channel agonist ameliorates the phenotype of a mouse model of amyotrophic lateral sclerosis.

Kv3 channel agonist ameliorates the phenotype of a mouse model of amyotrophic lateral sclerosis.

Journal: Acta neuropathologica communications

Published: February 17, 2025

The evolution of eukaryotic linear motifs governing the function of androgen receptor from fish to Homo sapiens.

The evolution of eukaryotic linear motifs governing the function of androgen receptor from fish to Homo sapiens.

Journal: Nucleic acids research

Published: December 17, 2024

Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscle.

Spinal and bulbar muscular atrophy: From molecular pathogenesis to pharmacological intervention targeting skeletal muscle.

Journal: Current opinion in pharmacology

Published: February 17, 2023

Introduction to the Special Issue "Skeletal Muscle Atrophy: Mechanisms at a Cellular Level".

Introduction to the Special Issue "Skeletal Muscle Atrophy: Mechanisms at a Cellular Level".

Journal: Cells

Published: January 28, 2023

Antagonistic effect of cyclin-dependent kinases and a calcium-dependent phosphatase on polyglutamine-expanded androgen receptor toxic gain of function.

Antagonistic effect of cyclin-dependent kinases and a calcium-dependent phosphatase on polyglutamine-expanded androgen receptor toxic gain of function.

Journal: Science advances

Published: January 06, 2023

Skeletal Muscle Pathogenesis in Polyglutamine Diseases.

Skeletal Muscle Pathogenesis in Polyglutamine Diseases.

Journal: Cells

Published: May 19, 2022

LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice.

LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice.

Journal: Nature communications

Published: February 16, 2022

Defective excitation-contraction coupling and mitochondrial respiration precede mitochondrial Ca2+ accumulation in spinobulbar muscular atrophy skeletal muscle.

Defective excitation-contraction coupling and mitochondrial respiration precede mitochondrial Ca2+ accumulation in spinobulbar muscular atrophy skeletal muscle.

Journal: Nature communications

Published: January 14, 2022

Motor Neuron Diseases and Neuroprotective Peptides: A Closer Look to Neurons.

Motor Neuron Diseases and Neuroprotective Peptides: A Closer Look to Neurons.

Journal: Frontiers in aging neuroscience

Published: June 11, 2021

Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism.

Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism.

Journal: Cells

Published: December 12, 2019

Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization.

Muscleblind acts as a modifier of FUS toxicity by modulating stress granule dynamics and SMN localization.

Journal: Nature communications

Published: October 19, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026